Search

everythinglearnresearchcommunity

for

Search:↓

Cocaine possibly mixed with levamisole caused a woman's skin condition and blood issues, which improved with treatment.

A man with Cronkhite-Canada syndrome improved significantly with immunosuppressive therapy.

Early-stage Alopecia Areata was effectively treated in less than six months.

The conclusion suggests a new treatment for infantile hemangiomas and a potential target for hair loss treatment.

The article suggests managing interferon beta therapy side effects in MS with dose adjustments, medications, and patient education.

Oral retinoids may help some patients with hard-to-treat lichen planopilaris, but more research is needed.

Finasteride can cause one-sided breast enlargement, which disappears after stopping the drug.

Younger patients and those with more hair loss are less likely to benefit from oral steroid treatment for hair loss, and low vitamin D may predict relapse.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

Oral steroids may effectively treat recurrent intussusception in children with ILH, possibly avoiding surgery.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

The document concludes that low-dose oral minoxidil successfully regrew hair in a patient with permanent hair loss after chemotherapy and stem cell transplant.

Isotretinoin with tacrolimus may be more effective short-term for treating frontal fibrosing alopecia than finasteride with tacrolimus.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

Tinea capitis can be misdiagnosed as bacterial infection in adult women but is treatable with antifungal medication.

Lenalidomide effectively and safely treats skin symptoms in pediatric lupus, reducing the need for prednisone.

Prurigo pigmentosa mainly affects middle-aged White and Asian women, often linked to a ketogenic diet, and is best treated with oral antibiotics.

A severe medication reaction required long treatment and led to hair loss and thyroid issues.

Oral tofacitinib may be an effective future treatment for children with severe alopecia areata, but more research is needed.

Frontal fibrosing alopecia is a hair loss condition in postmenopausal women, similar to lichen planopilaris, with ineffective treatments.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

Lichen planus is a skin condition that can resolve on its own, is linked to hepatitis C, and increases the risk of skin cancer.

Folliculitis decalvans is a rare scalp condition causing scarring hair loss, treated with long-term antibiotics and other medications, but it often comes back and is hard to manage.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

Different treatments for alopecia areata have varying success rates and side effects; intralesional steroids are most effective.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

JAK inhibitors may soon be a safe and effective treatment for alopecia areata.